SKI Market

Indian Indices

Sensex

84,065.75 485.35
( 0.58%)

Global Indices

Nasdaq

50,145.69 1,215.96
(2.49%)

Dow Jones

6,954.50 135.10
(1.98%)

Hang Seng

56,676.08 2,422.40
(4.46%)

Nikkei 225

10,359.93 50.71
(0.49%)

Forex

USD-INR

90.32 -0.07
(-0.08%)

EUR-INR

106.52 -0.28
(-0.26%)

GBP-INR

122.68 -1.05
(-0.85%)

JPY-INR

0.58 0.00
(-0.33%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Venus Remedies Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

526953

INE411B01019

467.2458657

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VENUSREM

13.98

987.69

EPS(TTM)

Face Value()

Div & Yield %

52.85

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	639.46	575.21	537.66	576.71	514.62	320.23
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	639.46	575.21	537.66	576.71	514.62	320.23
Other Income	30.69	11.32	10.17	8.43	50.37	34.93
Stock Adjustments	-0.93	5.00	-14.26	-3.19	7.36	-6.21
Total Income	669.22	591.53	533.57	581.95	572.35	348.95
EXPENDITURE :
Raw Materials	373.86	357.22	322.44	374.31	344.04	170.60
Power & Fuel Cost	4.91	4.99	4.17	3.78	3.39	3.41
Employee Cost	67.21	57.57	47.67	43.75	35.89	33.79
Other Manufacturing Expenses	12.34	10.07	6.18	6.47	4.51	3.63
Selling & Administrative Expenses	109.58	89.17	81.16	76.40	87.29	59.53
Miscellaneous Expenses	0.64	0.31	0.26	0.00	9.17	40.16
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	568.54	519.33	461.88	504.71	484.28	311.12
Operating Profit	100.69	72.21	71.70	77.25	88.07	37.84
Interest	0.00	0.00	0.00	0.00	12.73	13.05
Gross Profit	100.69	72.21	71.70	77.25	75.34	24.79
Depreciation	21.62	25.55	31.37	32.58	34.28	31.05
Profit Before Tax	79.07	46.66	40.33	44.67	41.06	-6.26
Tax	21.86	12.22	0.00	0.00	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	4.65	3.93	11.36	-4.32	-13.21	1.96
Reported Net Profit	52.56	30.50	28.96	48.99	54.27	-8.23
Extraordinary Items	8.10	0.37	0.01	0.00	23.44	-6.85
Adjusted Net Profit	44.46	30.13	28.95	48.99	30.83	-1.38
Adjustment below Net Profit	-0.48	-0.19	-0.46	0.24	-0.10	-0.47
P & L Balance brought forward	195.07	164.76	136.26	87.02	32.85	41.55
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	247.15	195.07	164.76	136.26	87.02	32.85
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	39.32	22.82	21.67	36.65	43.97	-6.67
Earnings Per Share(Adj)-Unit Curr	39.32	22.82	21.67	36.65	43.97	-6.67
Book Value-Unit Curr	441.01	380.48	357.63	336.21	313.10	269.21
Book Value(Adj)-Unit Curr	441.01	380.48	357.63	336.21	313.10	269.21

84,065.75 485.35 ( 0.58%)

50,145.69 1,215.96 (2.49%)

6,954.50 135.10 (1.98%)

56,676.08 2,422.40 (4.46%)

10,359.93 50.71 (0.49%)

90.32 -0.07 (-0.08%)

106.52 -0.28 (-0.26%)

122.68 -1.05 (-0.85%)

0.58 0.00 (-0.33%)